Ftse Mib
38.495,46
0,19%
DAX
22.483,14
0,98%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
95.765,41
-0,53%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Atara Biotherapeutics Inc (ATRA) Atara Biotherapeutics Inc (ATRA) Notizie

Atara Biotherapeutics Inc

ATRA
7,11
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:00:07
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202522:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
07/2/202500:34EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
29/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:30EDGAR2Form 8-K - Current report
21/1/202513:36EDGAR2Form 8-K - Current report
21/1/202513:30BWAtara Biotherapeutics Provides Update on Clinical Programs..
17/1/202522:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/1/202522:05EDGAR2Form 8-K - Current report
16/1/202514:30BWAtara Biotherapeutics Provides Regulatory and Business..
23/12/202422:00EDGAR2Form 8-K - Current report
27/11/202422:01BWAtara Biotherapeutics to Participate at the 7th Annual..
21/11/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202423:58EDGAR2Form 144 - Report of proposed sale of securities
18/11/202423:56EDGAR2Form 144 - Report of proposed sale of securities
18/11/202423:55EDGAR2Form 144 - Report of proposed sale of securities
18/11/202423:54EDGAR2Form 144 - Report of proposed sale of securities
13/11/202422:01BWAtara Biotherapeutics to Participate at the Stifel 2024..
12/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05EDGAR2Form 8-K - Current report
12/11/202422:01BWAtara Biotherapeutics Announces Third Quarter 2024 Financial..
05/11/202422:01BWAtara Biotherapeutics to Announce Third Quarter 2024..
15/10/202422:05EDGAR2Form 8-K - Current report
04/10/202422:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
11/9/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
05/9/202422:07EDGAR2Form SC 13D/A - General Statement of Acquisition of..
04/9/202422:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/9/202422:01BWAtara Biotherapeutics to Participate in the H.C. Wainwright..
03/9/202423:05EDGAR2Form 8-K - Current report
03/9/202422:16BWAtara Biotherapeutics Announces $36 Million Registered..
21/8/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:12EDGAR2Form 144 - Report of proposed sale of securities
16/8/202422:10EDGAR2Form 144 - Report of proposed sale of securities
16/8/202422:09EDGAR2Form 144 - Report of proposed sale of securities
16/8/202422:08EDGAR2Form 144 - Report of proposed sale of securities
16/8/202422:06EDGAR2Form 144 - Report of proposed sale of securities
15/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202423:05EDGAR2Form 8-K - Current report
12/8/202423:00BWAtara Biotherapeutics Announces Second Quarter 2024..
07/8/202422:01BWAtara Biotherapeutics to Participate in the Canaccord..
17/7/202422:16EDGAR2Form 8-K - Current report
17/7/202415:00BWAtara Biotherapeutics Announces U.S. FDA Acceptance and..
05/7/202422:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
Apertura: Min: Max:
Chiusura: 7,11

La tua Cronologia

NASDAQ
ATRA
Atara Biotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci